2. Diabetes C, Complications Trial Research G, Nathan DM, et al. The impact of intensive treatment of diabetes on the development and development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 3. Effect of intensive blood-glucose management with metformin on complications in overweight patients with kind 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. 4. Intensive blood-glucose management with sulphonylureas or insulin in contrast with typical therapy and at-home blood monitoring risk of complications in patients with sort 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. 5. Stratton IM, BloodVitals device Adler AI, Neil AW, Matthews DR, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): potential observational study. 6. Parkin CG, Buskirk A, Hinnen DA, Axel-Schweitzer M. Results that matter: structured vs. 2 diabetes. Diabetes Res Clin Pract. 7. Schnell O, Alawi H, Battelino T, et al. Self-monitoring of blood glucose in kind 2 diabetes: current research.

J Diabetes Sci Technol. 8. Cavalot F, Pagliarino A, Valle M, et al. Postprandial blood glucose predicts cardiovascular events and all-trigger mortality in type 2 diabetes in a 14-yr follow-up: classes from the San Luigi Gonzaga Diabetes Study. 9. Inzucchi SE, Bergenstal RM, Buse JB, BloodVitals device et al. Management of hyperglycemia in sort 2 diabetes: a affected person-centered strategy: place assertion of the American Diabetes Association (ADA) and BloodVitals health the European Association for the Study of Diabetes (EASD). 11. Boutati EI, Raptis SA. Self-monitoring of blood glucose as a part of the integral care of type 2 diabetes. 12. Klonoff DC, Blonde L, Cembrowski G, et al. Consensus report: the present function of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol. 13. Ceriello A, BloodVitals device Barkai L, Christiansen JS, et al. Diabetes as a case examine of chronic illness administration with a customized method: The position of a structured feedback loop.

Diabetes Research and Clinical Practice. 14. Malanda UL, Welschen LMC, Riphagen II, Dekker JM, Nijpels G, Bot SDM. Self-monitoring of blood glucose in patients with kind 2 diabetes mellitus who are usually not utilizing insulin. Cochrane Database of Systematic Reviews. 15. Polonsky WH, Fisher L, Schikman CH, et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results from the Structured Testing Program examine. 16. Young LA, Buse JB, Weaver MA, et al. Glucose self-monitoring in non-insulin-treated patients with type 2 diabetes in primary care settings: A randomized trial. 17. Kempf K, Kruse J, Martin S. ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention considerably improves glucometabolic control of patients with type 2 diabetes mellitus. 18. Hortensius J, Kars MC, Wierenga WS, Kleefstra N, Bilo HJ, van der Bijl JJ. Perspectives of patients with type 1 or insulin-handled type 2 diabetes on self-monitoring of blood glucose: a qualitative research.

19. Childs BP, Grothe JM, BloodVitals device Greenleaf PJ. Strategies to Limit the Effect of Hypoglycemia on Diabetes Control: Identifying and Reducing the Risks. 20. McQueen R, Ellis S, Maahs D, Anderson H, Nair K, Campbell J. Frequency of Continuous Glucose Monitoring Use and change in Hemoglobin A1C for Adults with Type 1 Diabetes in a Clinical Practice Setting. 21. Gonder-Frederick L, Nyer M, Shepard JA, Vajda K, Clarke W. Assessing concern of hypoglycemia in children with Type 1 diabetes and their mother and father. 22. Copeland KC, Silverstein J, Moore KR, et al. Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in kids and BloodVitals device adolescents. 23. Standards of Medical Care in Diabetes--2018. Diabetes Care. Jan; 41(Supplement 1): S3-S3. 24. Barry HG. Factors Affecting Blood Glucose Monitoring: BloodVitals SPO2 device Sources of Errors in Measurement. Journal of Diabetes Science and Technology. 25. Jing W, Janice Z, Judith TM, Denise C-P, Susan MS, Linda S. Self-Monitoring of Blood Glucose Is Related to Problem-Solving Skills in Hyperglycemia and Hypoglycemia.

26. Cohen RM, Lindsell CJ. When the Blood Glucose and the HbA1c Don’t Match: Turning Uncertainty Into Opportunity. 27. Hirsch IB, Amiel SA, BloodVitals SPO2 Blumer IR, et al. Using Multiple Measures of Glycemia to Support Individualized Diabetes Management: Recommendations for Clinicians, Patients, and BloodVitals device Payers. Diabetes Technology & Therapeutics. 28. Tenderich A. Use of Blood Glucose Meters Among People With Type 2 Diabetes: Patient Perspectives. 29. Cypress M, Tomky D. Using Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes. 30. Grady M, Pineau M, BloodVitals SPO2 Pynes MK, Katz LB, Ginsberg B. A Clinical Evaluation of Routine Blood Sampling Practices in Patients with Diabetes: Impact on Fingerstick Blood Volume and Pain. Journal of Diabetes Science and Technology. 31. Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of selfmonitoring of blood glucose and hemoglobin A1c levels in T1D change clinic registry individuals. 32. Poolsup N, Suksomboon N, Rattanasookchit S. Meta-evaluation of the benefits of self-monitoring of blood glucose on glycemic management in kind 2 diabetes patients: an replace. 33. Klonoff DC, Lias C, Beck S, et al. Development of the Diabetes Technology Society Blood Glucose Monitor System Surveillance Protocol. J Diabetes Sci Technol. 34. Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of proof and consensus suggestions for care.